Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Protein Analysis Reagents
  4. Bioactive Small Molecules
  5. RD10188016

R&D Systems™ MC 1
SDP

Catalog No. RD10188016 Shop All Novus Products
Change view
Click to view available options
2 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No.
RD10188016 2 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. RD10188016 Supplier R&D Systems™ Supplier No. 8843/2

Customers require a valid business account associated to their profile to access pricing and ordering options.

missing translation for 'validMainframeMsg'

Description

A Tocris product, part of R&D Systems.

MC 1 is a selective lysine acetyltransferase EP300 Degrader PROTAC™. Displays selectivity for EP300 over CREBBP. Comprises an EP300-binding moiety (CPI-1612) joined by a linker to VH032 as the ligand for von Hippel-Lindau E3 ubiquitin ligase. MC 1 inhibits cell proliferation in a subset of cancer cell lines and can be used to investigate the noncatalytic functions of EP300 and CREBBP. PROTAC™ is a registered trademark of Arvinas Operations, Inc., and is used under license

Specifications

Chemical Name or Material (2S,4R)-1-((S)-2-(8-(2-(4-(6-((R)-2-(((S)-2-(4-Cyanophenyl)propyl)amino)-2-phenylacetamido)pyridin-3-yl)-1H-pyrazol-1-yl)acetamido)octanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide
Quantity 2 mg
Product Line Tocris
Target Histone Acetyltransferase Degraders
Molecular Formula C59H71N11O6S
Purity 95%
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.